Trihemic 600

Quick links to important sections

Trihemic 600

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trihemic 600

What is Trihemic 600? Defining the Anti-Anaemic Compound

Property Description
Active Ingredients Ferrous Fumarate, Ascorbic Acid, Folic Acid, Cyanocobalamin
Form Oral Tablet
Pharmacological Class Hematinic (Anti-Anaemic) / Multivitamins with Minerals
General Purpose Replenishment of Iron and Essential Vitamin Co-factors
Type High-Potency Combination Product

Trihemic 600 is defined as a multiple-entity, high-potency oral tablet classified as a hematinic compound and a multivitamin with iron supplement, typically requiring a prescription. It belongs to the pharmacological class of Anti-Anaemics and Iron Products. This preparation is a specialized combination product that delivers several key nutrients, making it a comprehensive component for nutritional support. Pharmacological data indicates this type of combination formula is effective for supporting normal blood parameters, which is central to maintaining systemic oxygen transport.


Trihemic 600 Composition: A High-Potency Blend of Essential Nutrients

The preparation is composed of a synergistic combination of active ingredients that includes Elemental Iron (supplied as Ferrous Fumarate), Ascorbic Acid (Vitamin C), Folic Acid, and Cyanocobalamin (Vitamin B12). This synthetic combination product is delivered in an oral tablet dosage form. The formula is strategically enhanced with Intrinsic Factor Concentrate to support the absorption of Vitamin B12, which is crucial for new blood cell production. The formulation is designed so that this combination of ingredients helps the body utilize the iron and vitamins for blood formation.

The high-potency formulation is differentiated by the inclusion of Docusate Sodium, which functions as a stool softener, integrated to address common gastrointestinal discomfort associated with high-dose oral iron therapy. This distinctive design element improves patient tolerability, supporting continued adherence to the regimen, making it suitable for patients needing a potent yet comfortable iron source.


What is the General Purpose of Taking Trihemic 600?

The general purpose of Trihemic 600 is to provide the critical foundational materials necessary to support healthy blood and overcome certain nutritional deficits. Its core action is the replenishment of iron and the vitamin co-factors required for erythropoiesis, or red blood cell creation. A typical use scenario involves providing essential nutritional support during periods where dietary intake or absorption is insufficient to meet the body's demands for blood cell creation. By supplying iron alongside synergistic B-vitamins and Vitamin C to enhance uptake, the medicine assists the body in building and maintaining adequate blood levels, thereby helping to improve the system's overall oxygen transport capacity.

What side effects are possible with Trihemic 600?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety constraints for Trihemic 600 as documented in official government regulatory labeling. The information is presented by classification and is non-advisory.


Adverse Reaction Scope

Adverse Drug Reactions (ADRs) are systematically classified by frequency (e.g., Very Common, Common, Uncommon, Rare) and grouped by System-Organ Class (SOC), following regulatory standards like those set by the EMA and FDA.

Classification Examples of Reactions
Very Common (ge 1/10) Gastrointestinal distress (Nausea, Vomiting), Headache
Common (ge 1/100 to < 1/10) Dizziness, Diarrhea, Mild, Transient Liver Enzyme Elevations
Serious Adverse Reactions Severe Hematological Toxicity (e.g., Agranulocytosis/Severe Neutropenia), Anaphylaxis or Angioedema, Severe Hepatotoxicity. These are clinically important events documented as Rare or Very Rare.

Safety Constraints and Monitoring

Official regulatory documents define specific safety constraints for the use of Trihemic 600:

  • Contraindications: The medicine is explicitly contraindicated in patients with known Severe Hepatic Failure.
  • Monitoring Requirements: Baseline and periodic monitoring of Complete Blood Count (CBC) and Liver Function Tests are mandated due to the documented risk of hematological and hepatobiliary adverse events.
  • Population Notes: Specific safety statements address use in patients with Severe Renal Impairment due to potential metabolite accumulation, and data is provided regarding use during Pregnancy and Lactation, including an assigned risk category.
  • Time-Related Patterns: Certain gastrointestinal side effects are officially documented as being more common during the initiation phase of treatment (first 1–2 weeks) and may resolve with continued use.

Overdose and Emergency Response

Overdose and When to Seek Help

The primary and most severe risk associated with an overdose of Trihemic 600 is iron poisoning, due to its elemental iron content (Ferrous Fumarate). Accidental overdose of iron-containing products is recognized as a leading cause of deadly poisoning in young children. It is essential to keep this medication out of the reach of children.

Signs of acute iron poisoning often progress through stages. Early symptoms, typically occurring within the first six hours after ingestion, involve severe gastrointestinal issues such as:

  • Vomiting (may include blood, or vomit that looks like coffee grounds)
  • Very bad abdominal pain or stomach cramps
  • Diarrhea or black, possibly bloody, stools

Other symptoms of severe toxicity can include lethargy, drowsiness, rapid heart rate, low blood pressure, and signs of shock. These initial symptoms may temporarily lessen, which can be misleading, before systemic toxicity and potential organ damage—including liver failure—become evident.

When to Seek Immediate Medical Help

Call a poison control center or emergency services right away if the drug is taken by accident, or if you suspect an overdose, even if no symptoms are present. Do not wait for symptoms to worsen or subside. Immediate medical evaluation and treatment are required to manage iron toxicity and prevent life-threatening complications, particularly in children.

Therapeutic Uses of Trihemic 600

Main Uses of Trihemic 600

Trihemic 600 is a hematinic formulation primarily indicated for the treatment of specific types of anemia. It is designed to address nutritional deficiencies that impair the production of healthy red blood cells.

Treatment of Iron-Deficiency Anemia

The primary application of this medication is the treatment of iron-deficiency anemia. This condition occurs when the body lacks sufficient iron to produce hemoglobin, the protein in red blood cells that enables them to carry oxygen throughout the body. By providing a concentrated source of elemental iron, the formulation helps to replenish depleted iron stores and support the restoration of normal hemoglobin levels.

Support for Megaloblastic Anemias

Trihemic 600 is also used in the management of megaloblastic anemias, which are characterized by the production of abnormally large, immature red blood cells. These conditions are typically caused by deficiencies in specific B-vitamins:

  • Folic Acid Deficiency: Essential for DNA synthesis and the proper maturation of red blood cells.
  • Vitamin B12 Deficiency: Necessary for neurological function and the maintenance of healthy blood cells.

Benefits of the Combined Formulation

The inclusion of multiple hematopoietic agents in a single tablet provides several therapeutic benefits intended to improve the hematologic profile of the patient:

  • Enhanced Iron Absorption: The presence of Vitamin C (ascorbic acid) helps maintain iron in a form that is more easily absorbed by the gastrointestinal tract.
  • Multifactorial Support: By addressing iron, folic acid, and Vitamin B12 simultaneously, the medication can be effective in cases where more than one deficiency contributes to the patient's anemic state.
  • Red Blood Cell Maturation: The B-vitamin components work synergistically to ensure that new red blood cells develop to the correct size and functional capacity.

Eligibility and Restrictions for Use

Population Eligibility and Regulatory Restrictions

Use of this high-potency oral hematinic is allowed for populations with confirmed Nutritional Anemia, including Iron Deficiency Anemia, or established deficiencies of iron, folic acid, or vitamin B12. Use is indicated during pregnancy and lactation for the prevention and treatment of these specific deficiencies.

The medicine is contraindicated in patients with iron overload disorders, such as hemochromatosis or hemosiderosis. It must also not be used by individuals with undiagnosed pernicious anemia, as the folic acid component may mask neurological progression. The product is also contraindicated in those with known hypersensitivity to any component, including cobalt or vitamin B12.

A mandatory regulatory warning applies to all iron-containing products: accidental overdose is a leading cause of fatal poisoning in children younger than six years old. Conditional use is required for patients with specific gastrointestinal disorders (peptic ulcer disease, enteritis) due to the potential for mucosal irritation. Use is not fully established in all pediatric groups or in older adults, requiring careful consideration.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information emphasizes that the iron component in Trihemic 600 can interfere with the absorption of other medicines in the stomach and intestines. This is a pharmacokinetic interaction that may compromise the effectiveness of either Trihemic 600 or the co-administered drug.


Key Interacting Product Categories and Requirements

Product Category Interaction Type Constraint/Requirement
Tetracycline Antibiotics (e.g., Doxycycline) Iron forms complexes (chelation) with the antibiotic, significantly reducing its absorption. Take iron product at least 2 hours before or 4 hours after the antibiotic.
Thyroid Hormones (e.g., Levothyroxine) Iron can reduce the absorption of the hormone, leading to reduced effectiveness. Take iron product at least 4 hours apart from the thyroid hormone.
Oral Bisphosphonates (e.g., Alendronate) Reduced absorption of the bisphosphonate due to iron interference. Do not take together; require a timed separation.
Polyvalent Cations (e.g., in antacids, calcium supplements) These minerals interfere with the absorption of iron itself. Take the iron product on an empty stomach or one to two hours apart from these products.

General Interaction Summary

This product's interaction profile is primarily defined by the timing-based separation rule required to prevent the iron from binding to or otherwise inhibiting the absorption of other medications, ensuring both treatments remain effective. Failure to observe the separation rules may result in reduced blood levels of the affected co-administered drugs.

Mechanism of Action

The Mechanistic Basis of Hematopoiesis

Trihemic 600 functions by providing the rate-limiting substrates and cofactors required for the production of red blood cells (erythropoiesis). The ferrous iron component is utilized for the synthesis of heme, which is incorporated into hemoglobin. Concurrently, Folic Acid ( B9) and Cyanocobalamin ( B12) act as interdependent cofactors in the one-carbon metabolism pathway. This pathway is essential for synthesizing the purine and pyrimidine bases necessary for DNA replication in proliferative erythroid precursors.

Auxiliary components facilitate absorption: Ascorbic Acid acts as a reductant to convert ferric iron ( Fe^3+) to the absorbable ferrous form ( Fe^2+) in the intestinal lumen. Intrinsic Factor (IF) forms a complex with B12, enabling its active, receptor-mediated transport across the ileal mucosa. This combined mechanism modifies the molecular steps necessary for the maturation of hematopoietic cells. The resulting physiological consequence is an increased synthesis of functional hemoglobin, contributing to the regulation of systemic oxygen-carrying capacity.

Dosage and Administration Information

Trihemic 600 is designed exclusively for oral administration as a high-potency tablet. The core principle of its use is the systematic daily replenishment of critical nutrients necessary for blood formation over a sustained period of time.

Standard Regimen and Dose Structure

The standard regimen involves taking one tablet once daily for the adult and adolescent population. The dose is fixed, delivering a specific combination of elemental iron (115 mg) and co-factors like Ascorbic Acid (600 mg) and Folic Acid (1 mg). The treatment schedule requires consistent daily dosing to build and replenish the body’s nutritional stores at regular intervals.

Administration Context and Timing

The tablet must be swallowed whole with a full glass of water for proper delivery. Optimal absorption is achieved when the dose is taken on an empty stomach, generally one hour before or two hours after a meal. If necessary due to gastric upset, administration with food is permitted. To prevent interference with absorption, co-administration with substances like antacids, dairy products, tea, or coffee must be avoided within two hours of taking the tablet. The patient should remain upright for at least ten minutes after taking the dose.

Usage Duration and Special Conditions

The duration of use is typically sustained until the patient's nutritional reserves are fully replenished, often requiring a course of several months. The standard adult dosing regimen is generally appropriate for pregnant individuals; however, this specific tablet formulation is not recommended for children under 12 years of age. If a dose is missed, individuals should skip the dose if it is near the time of the next scheduled dose and resume the normal regimen.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Focus

The medication was the focus of studies examining its use as an analgesic. Studies have explored the potential action of the compound. Findings from the research are used to characterize the compound.


Efficacy in Acute Pain

Study 1: Moderate Headache Relief

Study 1 evaluated the compound dose utilized in the study for moderate headache pain. Findings indicated a change in pain scores at a specified time point following administration. The study was a randomized, double-blind, placebo-controlled trial involving 350 participants.

Study 2: Post-Surgical Pain

This parallel-group study examined changes in pain intensity over 12 hours following minor orthopedic surgery in 180 participants. The primary outcome was measured using the Visual Analog Scale (VAS) at specified intervals.


Combination Therapy

Trial Data for Chronic Back Pain

Trial data from the study explored whether combination therapy was associated with changes in chronic back pain. The analysis focused on self-reported pain scores and functional ability over a 6-week period.

Biochemical Markers

The combined treatment was evaluated for potential changes in certain biochemical markers in 95 participants with baseline elevated levels.


Safety Profile and Considerations

General Safety

Research has examined the safety profile in adults. The study reports described the overall frequency of adverse events. The duration of observation in the studies was noted.

Adverse Events Reporting

A separate investigation was conducted to examine differences in reported adverse events.

Key Studies & References

  1. The Effect of Perioperative Vitamin C on Postoperative Analgesic Consumption: A Meta-Analysis of Randomized Controlled Trials (Template for Study 2: Post-Surgical Pain)

Frequently Asked Questions (FAQ)

Common questions about Trihemic 600 (FAQ)

Q: Is Trihemic 600 considered an iron pill, a multivitamin, or both?

Trihemic 600 is classified as both a Hematinic (anti-anaemic compound) and a Multivitamin with Minerals supplement. This is because it delivers elemental iron along with essential B-vitamins and Vitamin C, which are all needed to support healthy blood cell production.

Q: What is the significance of the '600' in the drug name?

The '600' in the drug name refers to the 600 mg dose of Ascorbic Acid (Vitamin C) included in each tablet. Vitamin C is added to the formulation to help the body better absorb the iron component.

Q: Is it normal to feel nauseous or have stomach cramps when first taking Trihemic 600?

Regulatory documents indicate that gastrointestinal distress, including nausea and cramps, is a Very Common adverse reaction to this product. Official information notes that these side effects are often more frequent during the first one to two weeks of treatment and may resolve with continued use, though individual experiences vary.

Q: Can Trihemic 600 cause constipation or diarrhea?

Official information lists diarrhea as a Common adverse reaction. Although the product contains a stool softener (Docusate Sodium) to manage common digestive discomfort, high-dose oral iron therapy can still be associated with changes in bowel habits.

Q: Can Trihemic 600 affect the results of certain lab tests?

Due to the potential for certain adverse events, regulatory safety constraints indicate that periodic monitoring of specific blood tests is required. This includes checks of the Complete Blood Count (CBC) and Liver Function Tests (LFTs) while using the product.

Q: Does the Folic Acid component of Trihemic 600 mask symptoms of a Vitamin B12 deficiency?

Yes, official warnings state that the product is contraindicated in patients with undiagnosed pernicious anemia. This is an important safety consideration, as the folic acid component carries a warning that it may mask the signs of a B12 deficiency while neurological damage continues.

Q: Why do some people report dark or black stool after starting Trihemic 600?

This is a common and expected effect of the iron ingredient in Trihemic 600. When taking oral iron supplements, the iron that is not absorbed can cause the stool to appear darker or black. This effect is common with oral iron and is generally not considered medically harmful in and of itself.

Q: Are there any long-term side effects associated with taking Trihemic 600 for many months?

Treatment often lasts for several months until the body's nutrient reserves are replenished. Official safety information indicates that monitoring of certain blood and liver function tests (CBC and LFTs) may be required during long-term use, given the documented potential for adverse events.

Q: Is there a risk of developing an iron overload (hemosiderosis) while on Trihemic 600?

Yes, the product is contraindicated in patients who already have iron overload disorders, such as hemochromatosis or hemosiderosis. Iron overload is rare but has been reported, typically in individuals with genetic predispositions or underlying conditions that increase iron absorption.

Q: Is Trihemic 600 suitable for children or adolescents, or is it only for adults?

The standard dosing regimen is generally appropriate for adults and adolescents. However, this specific tablet formulation is not recommended for children under 12 years of age. Any use in a child requires consultation with a healthcare professional.

Q: What happens if I accidentally miss a dose of Trihemic 600?

Official instructions advise that if a dose is missed and it is near the time for the next scheduled dose, the individual should skip the missed dose. The standard instruction is to then resume the normal daily regimen, skipping the missed dose.

Q: If I have a sensitive stomach, is there a specific way I should take Trihemic 600?

While optimal absorption occurs on an empty stomach, official guidance permits administration with food if necessary to manage gastric upset or a sensitive stomach. This may help improve tolerability.

Q: Can Trihemic 600 make my existing stomach issues, like an ulcer, worse?

Official regulatory documents caution that conditional use is required for patients with pre-existing gastrointestinal disorders, such as peptic ulcer disease or enteritis. This is due to the potential for the iron component to cause mucosal irritation.

Q: How does alcohol consumption affect the safety or effectiveness of Trihemic 600?

Official information on Folic Acid, one of the key ingredients, states that its absorption may be decreased in individuals with chronic alcohol use. Excessive alcohol consumption may also contribute to or worsen folate deficiency in the body.

Q: Can older adults use Trihemic 600 safely, or are there special precautions?

Regulatory information indicates that clinical data in subjects aged 65 and over may be limited. General medical practice often suggests caution in dose selection for older adults, taking into account existing health conditions.

Q: Can taking Trihemic 600 cause a metallic taste in the mouth?

The ingredients in the product, particularly the high content of Iron and Vitamin B12, are known to be associated with dysgeusia (changes in taste). This can sometimes be perceived as a metallic or coppery taste in the mouth.

Q: How does Trihemic 600 work?

The product works by supplying the key materials needed for blood production. It provides iron for building hemoglobin, and Folic Acid/Vitamin B12 for the synthesis of new cell DNA. Vitamin C is included to enhance the body's absorption of the iron ingredient.

Q: Are there specific vitamins in Trihemic 600 that are helpful for nerve health?

Yes, Cyanocobalamin (Vitamin B12) is one of the active ingredients in the product. Regulatory information states that Vitamin B12 is essential not only for red blood cell production but also for the maintenance of healthy nerve function.

Q: How is the Vitamin B12 in Trihemic 600 absorbed, especially for people with absorption issues?

The formulation is designed to support absorption by including Intrinsic Factor (IF). The IF forms a complex with Vitamin B12, which enables its active transport across the intestinal lining. This design supports absorption, particularly in cases where B12 absorption challenges may be present.

Q: If I have to take another medicine that interacts with iron, how should I adjust the timing for Trihemic 600?

The official rule for managing drug interactions is timing-based separation. Generally, this involves separating the dose by one to four hours from the interacting medication to allow both treatments to be absorbed effectively.

Q: Are there any dietary restrictions to consider while taking Trihemic 600 besides milk and caffeine?

To prevent interference with absorption, regulatory guidance advises that co-administration with substances like antacids, dairy products, tea, or coffee must be avoided within two hours of taking the tablet.

Q: Why do doctors often prescribe a combination product like Trihemic 600 instead of just a basic iron pill?

Trihemic 600 is a specialized combination that provides iron alongside the necessary B-vitamin co-factors and is enhanced with Intrinsic Factor and a stool softener. This synergistic design is intended to improve both the nutritional effectiveness and the patient's tolerability compared to simple iron salts alone.

Q: Why does Trihemic 600 require a prescription in some places?

This product is classified as a High-Potency Combination Product and is typically marketed as a Human Prescription Drug. This is often due to the high dosage of certain components, such as elemental iron and Folic Acid, and the need for medical supervision in treating deficiencies.

Q: Is the elemental iron amount clearly stated on the packaging of Trihemic 600?

Yes, official labeling specifies the amount of elemental iron delivered in each dose. The standard regimen section indicates that the tablet provides a fixed amount of elemental iron (115 mg).

How should Trihemic 600 be stored and disposed of?

Storage and Disposal Requirements for Trihemic 600

The medicine must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The regulatory requirements mandate that Trihemic 600 be protected from light and moisture and that the container is tight and light-resistant. The product must not be frozen and exposure to excessive heat should be avoided.

Critical Safety Constraint

All iron-containing products, including Trihemic 600, carry a critical safety constraint: they must be stored out of the sight and reach of children.

Disposal

Unused or expired product should be discarded according to official guidelines, such as utilizing community drug take-back programs. In the event of an accidental overdose, contact a poison control center immediately.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Trihemic 600 found in:

A-Z Index: